Maher appointed MD at bioscience investment specialist Growcorp

8/10/2004 - Irish Examiner

Bioscience investment specialist Growcorp has appointed Fintan Maher as managing director.  The group's chief executive, Prof Michael Donnelly, takes up the position of executive chairman and will continue in the role of managing partner of the European Bioscience Fund.

"Since establishing Growcorp four years ago," said Prof Donnelly, "we have reviewed 320 investment opportunities in the bioscience arena and have now assembled a portfolio of seven companies.

"The appointment of Mr Maher will enable us to manage the portfolio to the next stage of our investment strategy and secure exits for the companies that we are invested."

IGrowcorp, established in 2000, is a uniquely focused venture capital company specialising in early stage funding for the bioscience sector.
 
 
Copyright 2007 Growcorp Group. All Rights Reserved.
Office: Growcorp Group Limited, 3015 Lake Drive, Citywest Campus, Citywest, Dublin 24 | Telephone: +353 1 4661000 | Fax: +353 1 4661002
Site developed by 4wardwebdesign
2008
Galway and Dublin. Wednesday, 3rd December, 2008: Growcorp Group, the Irish investment vehicle, will earn over Eur 7m following the acquisition this week of Irish theranoistic company Neutekbio by Danish biotechnology development company Merrion Pharmaceuticals has signed a multi-million euro deal with Novo Nordisk to develop oral diabetes products.

2008
DUBLIN, Ireland, Nov 5, 2008 an international specialty pharmaceutical company, today announced that it has been awarded the Frost & Sullivan 2008 Osteoporosis Technology Innovation of the Year Award

2008
DUBLIN, Ireland, Nov 5, 2008 an international specialty pharmaceutical company, today announced that it has been awarded the Frost & Sullivan 2008 Osteoporosis Technology Innovation of the Year Award

2008
Merrion Pharmaceuticals the TCD based Irish American company has confirmed that it has begun a joint feasibility study on oral drug delivery with Swiss based multinational Ferring Pharmaceuticals.

2007
Merrion Pharmaceuticals Plc was admitted to the IEX today and commenced
unconditional trading.........

2006
Merrion Pharmaceuticals Ltd, Dublin, announced the successful......        

Enterprise START Programme As Enterprise Ireland are anxious to..........

Merrion Pharma raises Eur 5M ahead of 2007 float Dublin drugmaker..........

Pharma Firm Merrion Hires Funding Adviser Merrion Pharmaceuticals.........

2004
Maher appointed MD at bioscience investment specialist Growcorp.........

Biopharma Firm Plans Drug Launch.........

Investing in Ireland From World Pharmaceutical Frontiers..........